Results 1 - 20 of 54,964 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (31,340)
Refined by:
subject:
Covid-19 Vaccines
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 VariantNew England Journal of Medicine, 2021-05, Vol.384 (20), p.1885-1898 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102214 ;PMID: 33725432Digital Resources/Online E-Resources |
| 2 |
Material Type: Article
|
|
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964Full text available |
| 3 |
Material Type: Article
|
|
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Nature (London), 2021-05, Vol.593 (7857), p.130-135 [Peer Reviewed Journal]Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03398-2 ;PMID: 33684923Full text available |
| 4 |
Material Type: Article
|
|
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impactNature reviews. Immunology, 2022-01, Vol.22 (1), p.57-65 [Peer Reviewed Journal]2021. Springer Nature Limited. ;COPYRIGHT 2022 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00662-4 ;PMID: 34876702Full text available |
| 5 |
Material Type: Article
|
|
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionNature medicine, 2021-11, Vol.27 (11), p.2032-2040 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01540-1 ;PMID: 34588689Full text available |
| 6 |
Material Type: Article
|
|
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity dataThe Lancet (British edition), 2021-05, Vol.397 (10289), p.2043-2046 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01115-6 ;PMID: 33991480Full text available |
| 7 |
Material Type: Article
|
|
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trialThe Lancet (British edition), 2022-01, Vol.399 (10321), p.237-248 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02753-7 ;PMID: 34953526Full text available |
| 8 |
Material Type: Article
|
|
Myocarditis With COVID-19 mRNA VaccinesCirculation (New York, N.Y.), 2021-08, Vol.144 (6), p.471-484 [Peer Reviewed Journal]2021 American Heart Association, Inc. 2021 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.056135 ;PMID: 34281357Full text available |
| 9 |
Material Type: Article
|
|
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19New England Journal of Medicine, 2021-06, Vol.384 (23), p.2187-2201 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2101544 ;PMID: 33882225Digital Resources/Online E-Resources |
| 10 |
Material Type: Article
|
|
Considerations in boosting COVID-19 vaccine immune responsesThe Lancet (British edition), 2021-10, Vol.398 (10308), p.1377-1380 [Peer Reviewed Journal]2021 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;2021. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02046-8 ;PMID: 34534516Full text available |
| 11 |
Material Type: Article
|
|
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous InfectionNew England Journal of Medicine, 2022-03, Vol.386 (13), p.1207-1220 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2118691 ;PMID: 35172051Digital Resources/Online E-Resources |
| 12 |
Material Type: Article
|
|
Model-informed COVID-19 vaccine prioritization strategies by age and serostatusScience, 2021-02, Vol.371 (6532) [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abe6959Digital Resources/Online E-Resources |
| 13 |
Material Type: Article
|
|
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational studyThe lancet oncology, 2021-06, Vol.22 (6), p.765-778 [Peer Reviewed Journal]2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00213-8 ;PMID: 33930323Full text available |
| 14 |
Material Type: Article
|
|
COVID-19 vaccines: where we stand and challenges aheadCell death and differentiation, 2021-02, Vol.28 (2), p.626-639 [Peer Reviewed Journal]The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021. ;The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021 ;ISSN: 1350-9047 ;EISSN: 1476-5403 ;DOI: 10.1038/s41418-020-00720-9 ;PMID: 33479399Full text available |
| 15 |
Material Type: Article
|
|
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesNature (London), 2021-05, Vol.593 (7857), p.136-141 [Peer Reviewed Journal]Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03412-7 ;PMID: 33706364Full text available |
| 16 |
Material Type: Article
|
|
How bad is Omicron? What scientists know so farNature (London), 2021-12, Vol.600 (7888), p.197-199 [Peer Reviewed Journal]Copyright Nature Publishing Group Dec 9, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03614-z ;PMID: 34857948Full text available |
| 17 |
Material Type: Article
|
|
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort studyThe Lancet infectious diseases, 2021-11, Vol.21 (11), p.1529-1538 [Peer Reviewed Journal]2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2021 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00289-9 ;PMID: 34174193Full text available |
| 18 |
Material Type: Article
|
|
Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19)Postgraduate medical journal, 2020-12, Vol.96 (1142), p.753-758 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 0032-5473 ;EISSN: 1469-0756 ;DOI: 10.1136/postgradmedj-2020-138234 ;PMID: 32563999Full text available |
| 19 |
Material Type: Article
|
|
COVID-19 vaccines for patients with cancer: benefits likely outweigh risksJournal of hematology and oncology, 2021-02, Vol.14 (1), p.38-11, Article 38 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-021-01046-w ;PMID: 33640005Full text available |
| 20 |
Material Type: Article
|
|
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020-12, Vol.383 (27), p.2603-2615 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2020 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034577 ;PMID: 33301246Digital Resources/Online E-Resources |
Results 1 - 20 of 54,964 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (31,340)
Refine My Results
Creation Date
- Before 2017 (1)
- 2017 To 2017 (1)
- 2018 To 2018 (4)
- 2019 To 2020 (3,466)
- After 2020 (51,492)
-
More options
New Records
- New From Last Week (11)
- New From Last Month (231)
- New From Last 3 Month (1,061)
-
More options
Resource Type
- Articles (42,328)
- Newspaper Articles (7,848)
- magazinearticle (4,164)
- Reports (336)
- Web Resources (81)
- Reviews (72)
- Newsletter Articles (58)
- Text Resources (27)
- Conference Proceedings (26)
- Datasets (17)
- Books (3)
- Thesises (postgraduate) (3)
- References (1)
-
More options
Subject
- Coronaviruses (40,506)
- Covid-19 (27,951)
- Science & Technology (26,657)
- Life Sciences & Biomedicine (24,193)
- Pandemics (23,550)
- Immunization (21,999)
- Vaccines (18,693)
- Severe Acute Respiratory Syndrome Coronavirus 2 (17,760)
- Humans (14,173)
- Vaccination (12,937)
- Public Health (11,673)
- Infections (11,302)
- Disease Transmission (10,979)
- Sars-Cov-2 (10,845)
- Immunology (7,046)
- Covid-19 - Prevention & Control (6,628)
- Antibodies (5,674)
- Epidemics (5,350)
- Medical Research (5,291)
-
More options
Databases
- ProQuest Central (50,314)
- DOAJ Directory of Open Access Journals (20,231)
- PubMed Central (Open access) (19,842)
- Coronavirus Research Database (18,614)
- ROAD: Directory of Open Access Scholarly Resources (17,393)
- MEDLINE (14,138)
- Freely Accessible Journals (12,390)
- HighWire Press (Free Journals) (3,371)
- ProQuest One Psychology (2,936)
- SpringerOpen (2,511)
- Wiley-Blackwell Titles (Open access) (1,185)
- Nature_OA刊 (1,152)
- Public Library of Science (PLoS) Journals Open Access (1,045)
- BMJ Journals (Open Access) (933)
- US Government Documents (904)
- Taylor & Francis (Open access) (880)
- Free E- Journals (874)
- Journals@Ovid Open Access Journal Collection Rolling (789)
- Centers for Disease Control and Prevention (509)
- Sage Journals Open Access Journals (366)
-
More options
Language
Journal Title
- Bmj (1,103)
- Business World (932)
- Curēus (722)
- International Journal Of Environmental Research And Public Health (791)
- New York Times (4,163)
- Plos One (876)
- Reactions Weekly (2,250)
- The Washington Post (2,648)
- Vaccine (1,338)
- Vaccines (3,052)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||